| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |